Second, as Gal‐1 is a potentially targetable protein (Ouyang et al., 2011; Rubinstein et al., 2004), its inhibition might alleviate the detrimental effects in the tumor microenvironment and impede tumor immune escape. Here, LGALS1 is linked to neoplasm.